SRP-1005 not checked

Sarepta Therapeutics, Inc.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1 trial completes
Trials
1 active
1 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Huntington's Disease
Main trialPhase 1
“This is a first-in-human, multi-center trial studying the effects of SRP-1005 in participants with Huntington's disease (HD).”In the company’s words, NCT07536061 on ClinicalTrials.gov

Other drugs for Huntington's Disease

All 11 drugs for Huntington's Disease

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 1Recruiting 30 Nov 2027 A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 20 Nov 2026 · EU trials register (CTIS) updated 20 Nov 2026 · openFDA updated 20 Nov 2026

Follow SRP-1005

Following is part of Solo: you see every change to SRP-1005 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in